REGULATION OF CNS SYNAPTIC TRANSMISSION BY MGLURS
MGLURS 对中枢神经系统突触传递的调节
基本信息
- 批准号:6165211
- 负责人:
- 金额:$ 16.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-03-01 至 2002-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): Schizophrenia has been
associated with at least two receptor complexes, namely, dopamine and GLU.
Theories have been developed which invoke hypotheses supporting specific
roles for these neurotransmitters in schizophrenia. The overall goal of
this application is to investigate and characterize the cellular
pharmacology of presynaptic and postsynaptic mGLURs at pharmacologically and
electrically isolated native excitatory and inhibitory synapses, while
determining their role in an animal model of the GLU-NMDA Receptor
Hypofunction (NRF)-hypothesis of schizophrenia. Intracellular recordings
from a brain slice preparation of the dorsolateral septal nucleus (DLSN)
will be used to investigate the cellular actions of specific mGLUR agonists
and antagonists for the three GROUPs of mGLURs (I, II, III). The specific
aims of this application will determine: (1) the mechanisms by which an
endogenous excitatory transmitter, GLU, regulates its own release via
specific presynaptic mGLURs (autoreceptors); (2) how activation of mGLURs on
gamma-aminobutyric acid (GABA)ergic terminals regulates the release of GABA
via other types of presynaptic mGLURs (heteroreceptors); and (3) how
activation of a postsynaptic mGLUR may potentiate the NMDA component of an
excitatory synaptic terminal, a component suggested to be depressed in the
NRF hypothesis of schizophrenia. Finally, mGLUR mechanisms in control
animals will be compared with brains of animal models of schizophrenia from
rats treated chronically with PCP, a drug known to induce behavioral changes
similar to those seen in patients with schizophrenia. The DLSN slice
preparation has been chosen to study since DLSN contains the relevant
neuronal circuitry implicated in the GLU-NRF-hypothesis of schizophrenia as
proposed by Coyle (Fig. 3) and the DLSN expresses multiple types of mGLURs.
Furthermore, no comparable circuitry is available in a more reduced
preparation. These experiments will enhance our understanding of the
mechanisms of normal synaptic transmission and transmission in an animal
model of schizophrenia. Together these data may provide evidence for the
use of a novel group of drugs in the treatment of schizophrenia.
描述(改编自申请人的摘要):精神分裂症已被
与至少两种受体复合物,即多巴胺和GLU相关。
理论已经发展,援引假设支持特定的
这些神经递质在精神分裂症中的作用 的总目标
本申请旨在研究和表征细胞
突触前和突触后mGLURs的药理学,
电隔离的天然兴奋性和抑制性突触,而
确定它们在GLU-NMDA受体的动物模型中的作用
功能减退(NRF)-精神分裂症的假说。 细胞内记录
从背外侧隔核(DLSN)的脑切片制备
将用于研究特定mGLUR激动剂的细胞作用
和三组mGLUR(I、II、III)的拮抗剂。 具体
本申请的目的将确定:(1)
内源性兴奋性递质GLU通过以下途径调节其自身的释放:
特异性突触前mGLURs(自身受体);(2)mGLURs如何激活
γ-氨基丁酸(GABA)能末梢调节GABA的释放
通过其他类型的突触前mGLURs(异源受体);(3)如何
突触后mGLUR的激活可增强突触后膜的NMDA成分,
兴奋性突触末端,一个被认为是在兴奋性突触末端被抑制的成分。
精神分裂症的NRF假说 最后,控制mGLUR机制
动物将与精神分裂症动物模型的大脑进行比较,
长期服用PCP的大鼠,PCP是一种已知的诱导行为变化的药物
与精神分裂症患者相似。 DLSN切片
由于DLSN包含相关的
精神分裂症的GLU-NRF假说中涉及的神经元回路,
由Coyle提出(图3),DLSN表达多种类型的mGLUR。
此外,没有可比的电路在更简化的系统中可用。
准备. 这些实验将增强我们对
动物正常突触传递和传递的机制
精神分裂症的模型 这些数据可以为以下方面提供证据:
一组新药物在治疗精神分裂症中的用途。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOEL P GALLAGHER其他文献
JOEL P GALLAGHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOEL P GALLAGHER', 18)}}的其他基金
Exploration of KCC2: Role in Schizophrenia
KCC2 的探索:在精神分裂症中的作用
- 批准号:
6776932 - 财政年份:2003
- 资助金额:
$ 16.74万 - 项目类别:
Exploration of KCC2: Role in Schizophrenia
KCC2 的探索:在精神分裂症中的作用
- 批准号:
6677996 - 财政年份:2003
- 资助金额:
$ 16.74万 - 项目类别:
CORTICOTROPIN RELEASING FACTOR MECHANISMS AND COCAINE
促肾上腺皮质激素释放因子机制和可卡因
- 批准号:
2851686 - 财政年份:1999
- 资助金额:
$ 16.74万 - 项目类别:
CORTICOTROPIN RELEASING FACTOR MECHANISMS AND COCAINE
促肾上腺皮质激素释放因子机制和可卡因
- 批准号:
6515644 - 财政年份:1999
- 资助金额:
$ 16.74万 - 项目类别:
CORTICOTROPIN RELEASING FACTOR MECHANISMS AND COCAINE
促肾上腺皮质激素释放因子机制和可卡因
- 批准号:
6634247 - 财政年份:1999
- 资助金额:
$ 16.74万 - 项目类别:
CORTICOTROPIN RELEASING FACTOR MECHANISMS AND COCAINE
促肾上腺皮质激素释放因子机制和可卡因
- 批准号:
6378801 - 财政年份:1999
- 资助金额:
$ 16.74万 - 项目类别:
CORTICOTROPIN RELEASING FACTOR MECHANISMS AND COCAINE
促肾上腺皮质激素释放因子机制和可卡因
- 批准号:
6175747 - 财政年份:1999
- 资助金额:
$ 16.74万 - 项目类别:
REGULATION OF CNS SYNAPTIC TRANSMISSION BY MGLURS
MGLURS 对中枢神经系统突触传递的调节
- 批准号:
2452078 - 财政年份:1998
- 资助金额:
$ 16.74万 - 项目类别:
REGULATION OF CNS SYNAPTIC TRANSMISSION BY MGLURS
MGLURS 对中枢神经系统突触传递的调节
- 批准号:
2883456 - 财政年份:1998
- 资助金额:
$ 16.74万 - 项目类别:
REGULATION OF CNS SYNAPTIC TRANSMISSION BY MGLURS
MGLURS 对中枢神经系统突触传递的调节
- 批准号:
6363703 - 财政年份:1998
- 资助金额:
$ 16.74万 - 项目类别: